Clinical Trial Update: TOCCATA - Touch+™ for Catheter Ablation [NA]

View source ↗

Summary

Abbott's TOCCATA Touch+ catheter ablation trial completed and posted results; the study focused on atrial fibrillation and supraventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Supraventricular Tachycardia

Drugs mentioned

• TOCCATA Touch+ Catheter Ablation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation, Tachycardia, Supraventricular | NA | Status: COMPLETED | Results posted: 2014-06-03